Archives: Agenda

Closing Plenary Session in Stream A

1 stage, a variety of rapid-fire opinions, bold predictions and myth-busting from experts across the industry. Audience members will vote, agree or disagree, on each hot take! There’ll be a chance for the audience to pose some questions to the panel too.

The panel will answer the following:

• Biggest mistake in clinical trials today
• One thing pharma should stop doing
• One prediction for 2030
• What’s overhyped and what’s worth the hype
• What vendors misunderstand
• Where trials fail most often
• Biggest recruitment mistake
• Hot takes from the audience

1 seat available for event sponsor

• Bringing the site voice to study design: Partnering with investigators during protocol development to reduce amendments, deviations, and operational friction
• Preventing problems before they happen: Using real-world site feedback to proactively adjust study design and execution
• Acting as the connective driver between sponsor, CRO, and sites to ensure alignment, accountability, and continuity across the trial lifecycle
• Lessons from a lean biotech: Stepping beyond defined roles and filling operational gaps, ensuring data flow and maintaining patient safety
• Redefining success by measuring the unquantifiable impact of strong site relationships on recruitment, retention, and overall trial performance

• Embedding QA from day one: Shifting Quality from a reactive, inspection driven process to proactive design and execution
• Leveraging RBQM frameworks and real time data analytics to anticipate issues, prioritize oversight, and make informed decisions
• Integrating emerging technologies to streamline inspection readiness and improve data integrity
• Applying quality tolerance limits (QTLs), analytics, and cross functional strategies to drive quality forward, reduce deviation risk, and strengthen regulatory confidence
• Delivering future-ready QA practices aligned with ICH expectations to sustain a quality culture